DNA RNA and Cells

07 Jul 2008 Early findings show promise as AS1411 AML study proceeds to higher-dose stage
03 Jul 2008 VAVELTA(R) Phase II data presented at FACE
02 Jul 2008 MicroIslet Provides Safety and Efficacy Data Update
02 Jul 2008 Titan Pharmaceuticals Announces Spheramine(R) Initial Phase IIb Results
02 Jul 2008 Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles
30 Jun 2008 Introgen Submits ADVEXIN(R) Regulatory Applications in the U.S. and Europe
30 Jun 2008 Teva & ANP Announce That Atl/Tv1102, a Novel Drug for The Treatment Of Relapsing Remitting Multiple Sclerosis (Rrms), Demonstrated Significant Reduction In Disease Activity
25 Jun 2008 FDA approves Quark IND for DGFi, an siRNA therapeutic based on Silence Therapeutics’ Unique Proprietary Chemistry
25 Jun 2008 Osiris Therapeutics Announces $2 Million Milestone Payment for Clinical Progress of a Stem Cell Therapy for Type 1 Diabetes
22 Jun 2008 Oncolytics Biotech Inc. Announces U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
19 Jun 2008 Alnylam and Kyowa Hakko Form Alliance for the Development and Commercialization of ALN-RSV01 in Asia
18 Jun 2008 AVONTEC announces results of a multiple dose clinical phase I study with its drug candidate AVT-02 UE ointment after topical treatment in male healthy volunteers
17 Jun 2008 Aastrom to Initiate Phase II Clinical Trial Using Cardiac Repair Cells Derived From Patient's Own Bone Marrow for Treatment of Severe Chronic Heart Failure
16 Jun 2008 Opexa Therapeutics Presents Monocyte-Derived Islet Cell Research at the International Society for Stem Cell Research Annual Meeting
15 Jun 2008 AMT prepares for submission of Marketing Authorization Dossier for AMT-011 (Glybera(R))
12 Jun 2008 NOXXON Pharma AG Announces Licensing and Discovery Collaboration with Eli Lilly and Company
12 Jun 2008 Targeted Genetics Announces Positive Phase 1/2 tgAAC94 Data Presented at Annual European Congress of Rheumatology
10 Jun 2008 Isis Highlights Robust Drug Portfolio for Diabetes and Obesity at ADA Conference
09 Jun 2008 Gentium Announces Update from Data Safety Monitoring Board Review of the Phase III Treatment Trial of Defibrotide for Severe Veno-Occlusive Disease
08 Jun 2008 Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
04 Jun 2008 Nuvelo Initiates Phase 1B Clinical Trial of Anticoagulant NU172
04 Jun 2008 Newly Published Study Shows OPKO's siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
03 Jun 2008 Isis' Partners Present Clinical Data on Antisense Drugs at the American Society of Clinical Oncology
03 Jun 2008 EMEA provides Guidance on Phase III Design and Approval Requirements
03 Jun 2008 Anti-TGF-beta Antisense AP 12009 shows very good Safety and Tolerability in Systemic Treatment of Pancreatic Carcinoma, Malignant Melanoma and Colorectal Carcinoma

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up